Clinical Trials Directory

Trials / Unknown

UnknownNCT01834105

Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1

Study on the Molecular Mechanism of Postmenopausal Osteoporosis With Kidney Yin Deficiency Syndrome From CLCF1 Interventing on JAK-STAT Signaling Pathways

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Fujian Academy of Traditional Chinese Medicine · Academic / Other
Sex
Female
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study use RT-PCR and Western Blot technique to detect the expression of CLCF1 mRNA and protein in POP Kidney Yin deficiency group and healthy group to verify the relevance between CLCF1 and POP the kidney Yin deficiency syndrome.Through siRNA and overexpression,observe the mRNA and protein 's expression of CBP、JAK1、STAT4 and the protein phosphorylation of JAK1、STAT4 in JAK-STAT signal to reveal the CLCF1 regulate the CBP's mechanism.Use the Liuwei Dihuang Pills to detect the effect of treatment ,compare use or not the Liuwei Dihuang Pills to detect the mRNA and protein 's expression of CLCF1、CBP etc.Aim to clarify the POP kidney Yin deficiency molecular mechanism.

Conditions

Interventions

TypeNameDescription
DRUGLiuwei Dihuang Pills

Timeline

Start date
2012-01-01
Primary completion
2014-12-01
First posted
2013-04-17
Last updated
2013-04-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01834105. Inclusion in this directory is not an endorsement.